The Director General of The National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye has on denied Paxherbal product as treatment for Coronavirus.
Prof. Adeyeye, revealed on Saturday that no clinical study has been done on any product to prove their efficacy.
The Director-General of NAFDAC further debunked the information spreading on social media.
She said; “Until a clinical study is done in a scientific manner, no herbal medicine manufacturer can claim effectiveness to treat COVID-19 associated symptoms.
“PAXHERBAL, a pharmaceutical company applied for listing of Pax Herbal Cugzin Capsule 290mg, and was approved by the agency and listed as ‘Safe to use.’
“Once the product is able to meet all requirements, a listing status is granted with a clear disclaimer that states clearly that the claims have not been evaluated by NAFDAC.
“The applicant can arrange for clinical trials at this stage that will involve the use of human subjects in order to prove the efficacy of claim for treatment following laid down procedures and with the approval of NAFDAC,” She made known.